Hexo (TSX:HEXO) Stock Soars 9% as Revenue Nearly Doubled in Q2

Hexo (TSX:HEXO)(NYSE:HEXO) stock soared by 9% shortly after the opening bell, as investors cheered a strong rise in revenue in the second quarter.

| More on:

Hexo (TSX:HEXO)(NYSE:HEXO) released its second-quarter financial results on Thursday morning. Hexo stock soared by 9% shortly after the opening bell, as investors cheered a strong rise in revenue.

The pot company strengthened its positions in several key Canadian markets outside Quebec while maintaining its leading competitive position in Quebec.

Hexo posted a loss of $20.8 million in the second quarter

Hexo is a consumer packaged goods cannabis company, which creates and distributes products to serve the global cannabis market. It serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis, and Original Stash brands, and it serves the medical market under HEXO medical cannabis.

Hexo posted a loss of $20.8 million in its most recent quarter, as revenue nearly doubled from a year earlier.

The cannabis company said its loss stood at $0.17 per diluted share for the quarter ended January 31.

The result compares to a loss of $298.2 million, or $4.52 per diluted share a year earlier, when the company incurred significant one-time charges related to its goodwill and intangible assets.

Hexo’s total net revenue were $32.8 million, up 94% from the same quarter a year earlier and 12% up from the first quarter of fiscal 2021 ended October 31, 2021. The company achieved positive adjusted EBITDA. This quarter marks Hexo’s seventh consecutive quarter of adjusted EBITDA improvement.

Non-beverage Canadian adult-use revenue increased by 72% from the second quarter of 2020.

Adult-use net revenue rose 10.5% in the second quarter, marking the fifth consecutive quarter of growth.

Hexo remains number one in Quebec

Hexo has kept its number one position for market share in Quebec while increasing adult-use net revenue in the rest of Canada to 49% of the company’s sales mix, up from 44% in the first quarter of 2021.

Sebastien St-Louis, Hexo CEO and co-founder, said in a statement: “Our continued focus on delighting consumers has seen us increase our market share across Canada while maintaining the number one position in Quebec. We’re also very excited to have launched ‘powered by HEXO’ CBD beverages in Colorado. Our net revenues and gross margin have continued to improve year over year, bolstered by our premium product mix with the relaunch of UP Cannabis.”

UP Cannabis brand gross revenues increased to $3.2 million, representing 8% of total adult-use, non-beverage gross revenue in the second quarter of 2021 compared to less than 1% in the first quarter due to the successful relaunch of the UP brand at the end of first quarter.

Brand mix, including the UP Cannabis brand, increased non-beverage adult-use gross margin  to 37%, up from 36% in the first quarter.

Hexo has maintained the number one position in the beverages category with net revenues up 11% from the first quarter.

Last month, Hexo announced a deal to buy competitor Zenabis Global in a $235 million deal that will give the cannabis company a European footprint and strengthen its domestic business.

Sébastien St-Louis said the deal with Zenabis will help accelerate national and international growth. The acquisition would place Hexo firmly in the top three positions among licensed producers for sales of adult cannabis in Canada, according to the most recent interim quarterly financial statements.

Hexo stock is overvalued

While Hexo’s growth is impressive, it’s preferable to wait before buying shares, because Hexo stock is overvalued, with a P/S of 12.34.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned. The Motley Fool recommends HEXO.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Will Canopy Growth Keep the Losing Streak Going in 2026?

Canopy Growth Corp (TSX:WEED) was one of the market's biggest losers in 2025.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »